Featured Articles in the Current Issue
Technology has great potential for the future of glaucoma care.
Prevent musculoskeletal disorders in day-to-day practice.
Complex glaucomas can be controlled without jeopardizing patient health.
Where are we now?
As a stand-alone procedure or combined with cataract surgery, KDB goniotomy provides excellent clinical results and exceeds margins for MIGS.
Reduce the number of drops by combining medications into one bottle.
Consider the data and put safety first.
Departments and Columns
Glaucoma News Briefs
- Glaucoma Practice in the COVID-19 Era
- Guidelines for Reopening Ambulatory Surgery Centers
- FDA Approves Breakthrough Durysta Sustained-Release Glaucoma Implant
- iSTAR MIGS Implant Effective in Two Trials
- AI-Supported Test Gives Early Warning on Glaucoma Progression
- Graybug Studying Sustained-Release Glaucoma Drug
- Iridex Introduces New MicroPulse Device
- Ocular Therapeutix: Positive Data on Long-Term Implant
- New Type of Perimetry Found Highly Accurate
- China Uses Real-World Data to Approve Xen Stent
- Incarcerated Glaucoma Patients Struggle With Adherence
- Nicox Clinical Trial Update
- Understanding the Causes of Pseudoexfoliation Glaucoma
- XEN-Augmented Baerveldt vs Ahmed Glaucoma Valve
- Glaucoma May Be Treatable by Gene Therapy
- Study: Raising Eye Pressure Causes Glaucoma
- Verana Health Will Handle End-to-End IRIS Registry Administration
- Trabeculectomy Effective in Cataract–Glaucoma Surgery
- New, Detailed Phase 3 Data on Durysta Implant Presented at ASCRS
- Goniotomy With Kahook Blade in Cataract Surgery Effective
- Patient Satisfaction With Glaucoma Eye Drops
- MIGS Decision-Making Discussed at ASCRS